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Xth International Congress of Nephrology
The Xth International Congress was held in London on July
26—31, 1987. The following reports were presented by members
of the Executive Committee to the membership. Two new
awards—The Jean Hamburger Award and the A.N. Richards
Award—were instituted with the London Congress. The award
statements are presented in this summary.
President's Report, 1984—87
EDITORS
In accord with the purposes of the International Society of
Nephrology to foster and develop the scientific basis of
Nephrology, programs in four broad areas were advanced.
I. Programs to foster the development of nephrology in areas
where the discipline is not highly developed
A. Postgraduate courses in developing countries. Three
postgraduate courses were sponsored: one in Nairobi, Kenya,
on Renal Diseases and Electrolyte Disorders, June 2—6, 1986; a
second in Cairo, Egypt, entitled "African Kidney and Electro-
lyte Conference," February 22—26, 1987; and a third in Rabat,
Morocco, entitled 'International Postgraduate Course of
Nephrology," March 25—28, 1987. The courses were concen-
trated in various parts of Africa in order to make a coherent
impact in a specific region and avoid ineffectual diffusion. These
meetings not only provided a forum for scientific education and
exchange, but also facilitated the formation of the African
Society of Nephrology.
B. Workshops and symposia were sponsored with and with-
out financial support in various parts of the world.
C. ISN Fellowship program. This program provided for the
selection and appointment in any one year of six fellows from
developing nations to recognized nephrology units. Care was
taken to insure that only those fellows would be accepted who
had a position in their home country that would be assumed
upon completion of training.
D. Program for visiting scholars to laboratories in developing
countries. This program was designed to support a visit of a
well-recognized nephrologist who would be willing to commit a
period of six weeks to three months to a nephrology unit in a
developing area. The aim was to establish more or less perma-
nent channels of communication to help the developing unit
inaugurate appropriate local programs and send fellows away
for research and clinical training.
E. Volumes of the proceedings of the Los Angeles Congress.
A total of 238 sets of volumes were distributed to Africa (150)
and Latin America (88). Volumes of the proceedings of the
Tokyo Congress in 1990 will, if possible, also be donated.
F. A limited amount of money was allocated to facilitate
revision of manuscripts of merit submitted to Kidney Interna-
tional from laboratories where nephrology was only at a begin-
ning stage.
II. Programs to advance the scientific discipline of
nephrology
A. Forefronts Symposia. The Society will sponsor two Fore-
fronts Symposia per year. The purpose of these symposia is to
provide a channel for the introduction into nephrology of
flanking scientific disciplines not now represented but which
give great promise for advancing the field. The proceedings of
one or both meetings will be published in abbreviated or
complete form so as to make available the contents of the
symposia to the membership. The first such symposium was
entitled "Molecular Biology and the Kidney" and was held in
Pinehurst, North Carolina, September 14—17, 1986.
B. Scientific Commissions. The goals of the Commissions are
to guarantee scientific input of the highest quality from out-
standing scientists. The Scientific Commissions should be es-
tablished in those areas of science where cooperation between
nephrologists and non-nephrologists would be desirable and
fruitful. These forums would facilitate the introduction of newly
developing areas in basic science into nephrology and would be
complementary to the Forefronts Symposia. Three Commis-
sions have thus far been established: Biophysics, History of
Nephrology and Cell Biology.
III. Programs to strengthen the structure of the ISN
A. Archives of the ISN. Pertinent data and documents about
activities and officers of the ISN and ISN Congresses since the
foundation of the Society are being assembled to furnish a
written record of the Society's structure and activities.
B. A History of the ISN since its inception is being written.
C. An ISN Membership Directory has been published as a
supplement to Kidney International, May 1987.
D. Travel Grants (120) were awarded to attend ISN Congress
in London.
E. Informa ton about ISN activities and programs are pub-
lished in K! as a special section, International Society of
Nephrology.
IV. Honorary awards
Honorary awards were established to recognize outstanding
work in the field of clinical nephrology and basic research.
These awards would serve the function of highlighting distin-
guished individuals in the discipline and would constitute
rallying points and goals for members of the Society.
The Jean Hamburger Award was granted jointly to Drs.
Willem Kolif and Belding Scribner. The AN. Richards Award
was granted to Dr. Robert Berliner.
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Treasurer's Report, 1984—87
The three year period from 1/1/84 to 1/1/87 has been one of
considerable growth and accomplishment for the International
Society of Nephroiogy. During this time the financial stability of
the Society has become well established and the Society's
resources have been used in increasing amounts to fund a
variety of educational programs around the world.
As shown in Figure 1, the ISN fund balance grew from
$698,649 in 1984 to $862,418, an increase of 23.4%. This
represents an increase of 161% from the previous period
beginning 1/1/81. This growth in the treasury of the ISN has
been accomplished in part by a dues increase, a relative
reduction of administrative expenses, returns on investment of
reserve funds and income from Kidney International,
As seen in Figure 2, ISN dues were increased for the first
time in four years, from $75 to $100 for 1987. Only $5 of this
amount, however, represents an increase of ISN dues, with $20
going to the publisher for increased subscription costs of
Kidney International.
The administrative expenses of the ISN have decreased from
26.6% of our total budget in 1983 (Fig. 3) to 15.04% of the total
budget in 1986 (Fig. 4). Most significantly, however, the support
for educational programs has grown 327% from $52,925 in 1983
to $225,938 in 1986 (Fig. 5). This reflects the initiation of a
number of new educational programs including the interna-
tional Fellowship Training Program, the Forefronts in Nephrol-
ogy symposium and a series of nephrology programs in devel-
oping nations.
It is the goal of the JSN to maintain a fund balance reserve of
$800,000, the income from which, along with the annual income
from members dues and Kidney International, will allow the
continuation and expansion of the Society's educational and
scientific programs. It is through such programs, the publication
of Kidney Intc'rnational and the sponsorship of symposia,
workshops and International Congresses that we can best
achieve our primary mission of disseminating knowledge in the
field of nephrology throughout the world.
ROBERT W. SCHRIER
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Secretary General's report, 1987
The 1993 XlIth International Congress of Nephrology will be
located in Jerusalem, Israel,
The composition of the ISN 1987—1990 Nominating Commit-
tee is: Paul Michielsen (Chairman) (Belgium), Franklin H.
Epstein (USA), Gerhard Giebisch (USA), Richard J. Glas-
sock (USA), Cohn 1. Johnston (Australia), Norman F. Jones
(UK), Franciszek Kokot (Poland), Jean-Philippe Méry
(France), Jose C. Pena (Mexico), Mordecai M. Popovtzer
(Israel), and Yawara Yoshitoshi (Japan).
The newly elected Officers and Councillors are: President-
Elect: Roscoe R. Robinson (USA), Vice-President: John
Stewart Cameron (UK), Secretary General: Claude Amid
(second term) (France), 'rreasurer: Robert W. Schrier (third
term) (USA). Councillors: Barry M. Brenner (USA), Saulo
Klahr (USA), Gerhard Malnic (Brazil), D. Keith Peters
(UK), Nobuhiro Sugino (Japan).
. The composition of the ISN 1987—1990 Management Com-
mittee is: Klaus Thurau, FRG (President), Roscoe R. Rob-
inson, USA (President-Elect), Claude Amiel, France (Sec-
retary General), Robert W. Schrier, USA (Treasurer),
Thomas E. Andreohi, USA (Editor Kidney International),
Saulo Klahr, USA (Councillor), D. Keith Peters, UK (Coun-
cillor).
Statement by President-Elect
CLAUDE AMIEL
I am deeply honored for the opportunity to serve as President
of our Society. I will do my utmost: to uphold the philosophy of
the Society, as expressed in our constitution; to protect the
traditions; and, at the same time, to be open and responsive to
the changing needs of our Society.
Nephrology, as represented by our Society, has always had
its roots in science, basic and clinical. It is this broad, intellec-
tual approach which makes this Society much more than just an
"organ-oriented" association.
One important task we face in the future, to maintain this high
standard, is that of being open to discoveries and developments
in the many, rapidly evolving fields of science. A second task is
that of remaining open to mutual exchange and interaction
between basic and clinical science. The standard is set funda-
mentally by the quality and intensity of this interaction. Clinical
and basic science essentially constitute an entity. Conducted in
isolation, both lose; conducted in conjunction, both benefit.
A third important task is that of advancing nephrology in
those areas of the world where nephrology has yet to realize its
fullest potential. There are enormous differences in this world.
People have a right to look to an international society, such as
ours, to assume the responsibility for helping those colleagues
of ours, who work in those areas, to establish modern nephrol-
ogy.
The importance of these tasks is attested to by the multiplic-
ity of programs the Society has initiated largely in the past three
years and on which you have heard Dr. Seldin report.
A tremendous momentum has been achieved by our Society.
The key to maintaining this momentum lies with each of you
seated here. No program runs of its own. It is the personal
element that lies at the center of it all. We all have to do our best
to assure that nephrology continues to draw young scientists
and clinicians to the field, since the very quality and future of
our Society will depend on the quality of the young.
Dr. Seldin, during his Presidency, has forcefully lead our
Society toward fulfilling these functions. He has done so with
integrity, remarkable energy, and quality.
Editor's Report 1987
KLAUS TF1URAU
Kidney International began, with R. R. Robinson as Editor,
in 1971. The current editorial staff, including the Editor and
Associate Editors, assumed responsibility for Kidney Interna-
tional in 1984. This report provides some relevant data on the
publication process for Kidney International.
Submissions and acceptances
Figure 6 indicates that the number of original investigative
manuscripts submitted to Kidney International was approxi-
mately 100 in 1971. The number of submitted manuscripts has
grown monotonicahly, reaching a steady-state level of approxi-
mately 500 per year beginning in 1985. These manuscripts are
approximately equally divided between Clinical Investigation
and Laboratory Investigation; more specifically, the ratio of
Clinical Investigation manuscripts to Laboratory Investigation
manuscripts submitted is 1:08.
Original manuscripts are sent to referees selected on a
world-wide basis by the Editor and Associate Editors. There
are a minimum of two, but generally three referees per manu-
script. Table I indicates that the acceptance rate has remained
remarkably constant—at approximately 33%—since the incep-
tion of Kidney International in 1971. Table 2 indicates that the
Table 1. Acceptance Rate: Original manuscripts
Acceptance
Year rate %
1971 32
1972 34
1973 37
1974 27
1975 32
1976 32
1977 35
1978 38
1979 43
1980 39
1981 29
1982 35
1983 37
1984 39
1985 37
1986 33
1987 34
Manuscript type
Clinical Investigation
Laboratory Investigation
Table 2. Acceptance rate: 1987 Manuscripts
Acceptano
Number rate %
257 34
237 32
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acceptance rate for Clinical Investigation manuscripts and
Laboratory Investigation manuscripts is approximately the
same.
Review and publication time
For 1986—87, the mean time for first review—that is, the
interval of time between when a manuscript is received and
when the editorial office communicates for the first time with
the corresponding author—is now approximately 60 days. The
interval of time between when a manuscript is accepted for
publication and when it appears in Kidney International is
approximately 5.5 months.
Published content
The relevant data on published content for Kidney Interna-
tional are presented in Figure 7. As indicated in Figure 7, the
number of published original manuscripts appearing in Kidney
international has grown from approximately 75, in 1972, to
approximately 180, in 1986 and 1987. The number of editorial
pages published in 1972 was about 1,600. Currently Kidney
international Contains about 2,200 editorial pages annually.
T.E. ANDREOLI, Editor
C. AMIEL, Associate Editor
J.P. KNOCHEL, Associate Editor
Presentation of the A.N. Richards Award
Gerhard Giehisch to Robert W. Berliner
We honor two prominent renal physiologists: we pay special
respect to A.N. Richards by instituting the new A.N. Richards
Award of the International Society of Nephrology, and to R.W.
Berliner, a very dear friend of mine, who is the first recipient of
the Award.
Let me first say a few words about Alfred Newton Richards,
one of the founders of modern renal physiology and a nephrolo-
gist to whom we pay tribute by this new award. A.N. Richards
was born in 1876 in Stamford, New York. He came from a
simple but educated midwestern family and background, en-
tered Yale College in 1897. He graduated with honors in
Chemistry and was stimulated early by his contact with Phys-
iological Chemistry, then taught by R.H. Chittenden. After
leaving Yale, he moved on and received his Doctorate from the
Graduate School at Columbia University. After a short period
he advanced to be Chairman of the Department of Pharmacol-
ogy at Northwesten University but soon left and settled in
Philadelphia where he headed for 36 years the Department of
Pharmacology at the University of Pennsylvania.
Figure 8 shows Richards as a young man at the beginning of
his career in the Pharmacology department. Besides being a
devoted and successful department chairman, and an effective
and incisive administrator—much later he headed a special task
force during World War II to get penicillin into production, and
he served as chairman of the committee on medical research of
the Office of Scientific Research and Development during
World War 11—he was what we remember him best for—an
outstanding, persevering and distinguished investigator who
made lasting contributions to nephrology and who placed renal
physiology on a solid foundation.
It is only within the historical background of his times that the
-..C Dh..-.-1.' h f11,, ,nnrpricted
Until the 1920's, much of renal physiology was empirical and
speculative; glomerular function and the mechanisms of urine
formation were uncertain, tubular functions ambiguously de-
fined, and the existence of secretion hotly debated.
What Richards did was to provide the experimental tools and
the requisite information necessary for a rational and experi-
mentally verifiable basis of glomerular and tubular function.
Stimulated early in his career by Dale and Cushny, it was he
and his colleagues who skillfully worked out and introduced
powerful micropuncture and microanalytic methods for the
study of renal function at the level of the single nephron.
The collection and careful analysis of fluid samples from the
giomerular space and from specific tubule sites—a simple and
unambiguous approach—allowed for the precise definition of
what happened in the glomerulus and along the tubule. Not only
was renal physiology for the first time put on a firm basis, but a
whole body of clearance data could now be interpreted in a
meaningful way by reference to a framework of well-localized
renal functions.
Richard's scientific achievements were distinguished by be-
ing timely, incisive and conclusive. We should not forget his
colleagues, particularly Joseph Wearn who was associated with
the first glomerular punctures, and Arthur Walker, Jean Oliver
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and Phyllis Bott who did the first mammalian work. By provid-
ing the tools for the direct study of renal function, A.N.
Richards and his associates permanently transformed renal
physiology. A new period of renal physiology was initiated by
them and its impact is still with us.
Figure 9 shows A.N. Richards in his prime, he was 57 years
old when this portrait was painted in 1933, and in another one
(Fig. 10) Dr. Richards is surrounded by his colleagues and
associates (Arthur Walker at the left, standing, and Joseph
Wearn the fourth from the left).
Let me now turn to Robert Berliner, the first recipient of one
of our Society's most prestigious awards.
Bob Berliner was born in New York, and Figure 11 shows
him as a high school student. Like Richards, Bob Berliner also
went to Yale College, and to Columbia University where he
received an M.D. degree. During his early career, he was
inspired by two people, Robert Loeb, the distinguished chair-
man of the Department of Internal Medicine at Columbia, and
by James Shannon, at the NYU Division of Goldwater Memo-
rial Hospital. In 1950, Bob Berliner went to the National
Institutes of Health at Bethesda to head the Laboratory of
Kidney and Electrolyte Metabolism in the new Heart Institute
(Fig. 12). After 23 years, during which he established one of the
world's leading laboratories for the study of renal function, he
returned to Yale to become Dean of the Medical School. He
retired from the Deanship in 1985.
Bob Berliner's contributions to renal physiology, and to
science in general, were many and important. Broadly speak-
ing, they are twofold.
First, he made numerous, incisive discoveries in the field of
renal electrolyte and fluid transport. We all know his pioneering
efforts in the area of potassium transport. Joined by J. Orloff
and T. Kennedy, his clearcut demonstration, in the early fifties
that potassium ions were secreted by the renal tubules in
exchange for sodium, his investigations into the complex rela-
tionship between potassium and hydrogen transport and studies
of his team on the renal mechanism of ammonium excretion
signalled the beginning of a new area of renal transport studies
that continue to this day. Later, he was a seminal force in
elucidating the mechanisms mediating the concentration of the
I p
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urine. His efforts clarified many problems in such vital areas as
acid-base balance, renal mechanisms, regulating extracellular
volume, and potassium homeostasis.
Second, Bob Berliner's influence was felt by the scientific
community in a broader way. His critical analysis, his deduc-
tive power and his quick grasp of the essentials of a problem
made him a major intellectual power in the field. Anyone who
had the fortune to be associated with him, to discuss new data
with him, or approach him with a problem, came away the
better. His old friend Jack Orloff put it well: Bob Berliner
created an atmosphere that fostered excellence in all those with
the capacity to respond.
His laboratory always attracted some of the best students of
renal physiology, both from home and from abroad. Sur-
rounded by talented colleagues, he stimulated an impressive
and broad range of activities: It was in his laboratory that Moe
Burg, Jared Grantham, Maurice Abramov and Jack Orloff
developed the isolated, perfused mammalian tubule prepara-
tion, that John Dirks and Jim Clapp developed micropuncture in
the dog kidney, Barry Brenner worked on glomerulo-tubular
balance and Joe Handler and Jack Orloff studied the role of
cyclic AMP in vasopressin-induced stimulation of water trans-
port.
to have trained and influenced, in the broadest sense, so many
of the leading nephrologists of the world. There is hardly a
nephrology group that has not had a member who was associ-
I believe that one of Bob Berliner's greatest achievements is ated with Bob Berliner's laboratory in one way or another. In
jt
___
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this manner he influenced renal physiology and science in a
major and lasting way.
The last portrait shows Bob Berliner and his wife Lea (Fig.
13), who throughout his life has always been a source of
unfailing support and encouragement.
It is thus most appropriate that Bob Berliner be the first
recipient of the Alfred Newton Richards Award of the Interna-
tional Society of Nephrology for excellence in renal physiology.
This is in recognition of his contributions to renal physiology,
for his dedication to excellence, for his statesmanship in foster-
ing international cooperation in science and, last bitt not least,
for the inspiration he has been to the many that have been
fortunate to know him.
I would like to close on a somewhat personal note, and say of
Bob Berliner what the German poet, Hermann Hesse, said of
one of his favorite characters: he had a way of changing our life
such that greater things were demanded of us than we had
previously demanded of ourselves. For this we shall always be
grateful to Bob Berliner.
GERHARD GIEBIscH
Presentation of the Jean Hamburger Award
Jonas Bergstrom to Wi//em Koiff and Be/ding Scribner
The Jean Hamburger award is designed to honor individuals
for outstanding Investigations in Nephrology with a clinical
emphasis. It has been named after Dr. Jean Hamburger from
Paris, one of the founding fathers of nephrology, a pioneer in
renal transplantation, immunology and clinical nephrology.
Jean Hamburger, who was the vice president of the First
International Congress of Nephrology in Evian and Geneva in
1960 and is said to be the one who coined the term Nephro/ogy
as a collect name for all research and clinical activities related
to the kidneys.
The Jean Hamburger award will be given to two distinguished
nephrologists, whom I have always admired for their outstand-
ing contributions: Dr. Willem Kolif and Dr. Belding Scribner.
Dr. Willem Kolif was born in the Netherlands in 1911. As a
young doctor at the University of Groningen, he started in 1938
to explore the possibility of using cellophane as a membrane
material for dialysis of blood. When Hitlers' armies invaded the
Netherlands in 1940, the situation at the university became so
unbearable for Dr. Kolif that he decided to leave the university
and moved to a local hospital in Kampen, a small I)utch town.
After settling in Kampen he constructed, together with an
engineer, his first artificial kidney for clinical use, the rotating
drum kidney.
In February 1943 Kolif treated his first patient with the
artificial kidney. This was not the very first Patient dialyzed in
the history of medicine. Haas in Giesen had tried hemodialysis
10 years before, but under too primitive technical conditions
and too inefficiently to obtain any appreciable clinical effect.
Kolif had two technical advantages before any of his predeces-
sors, the access to cellophane as a membrane material and
heparine as an anticoagulant. Nevertheless, Kolffs' first attempt
was clinically unsuccessful. His second patient with chronic
renal failure showed a temporary clinical improvement but
died. However, KoIff and his team continued stubbornly in firm
belief that dialysis should sooner or later prove to be a success-
ful form of treatment, and began concentrating on treating
patients with acute, reversible renal failure. Still it was only
patient No. seventeen treated in 1945 who definitely owed her
survival to the artificial kidney.
During the last year of World War II when Kolif and his team
had to interrupt their clinical work, they built several artificial
kidneys. When the war was over these machines were given
away to hospitals in different countries. Other scientists built
their own machines, and the rotating drum artificial kidney was
spread all over the world. Kolff was the mastermind who in
excellent monographs and scientific articles described his med-
ical and technical experiences on uremia and dialysis. Gradu-
ally it became apparent that dialysis might be life-saving.
However, many influential authorities within the medical pro-
fession took a strong standpoint against dialysis with the
artificial kidney claiming that conservative treatment with diet
was superior.
In clinical nephrology KoIff should also be remembered for
being the first to construct a disposable dialyzer of coil type.
The Kolff-Watschinger dialyzer. The equipment was relatively
cheap and easy to handle, and very soon spread rapidly to
several centers. In fact, the popularity of the twin-coil dialyzer
paved the road for a rapid spread of dialysis treatment to
several centers both in Europe and in the United States.
Dr. Kolif moved to the United States in 1950, first to
Cleveland, Ohio and later to Salt Lake City, Utah as chief of the
Institute of Artificial Organs, where he continued his efforts to
improve dialysis treatment. Kolif has also made many other
fundamental contributions to medicine, among which was the
development of the artificial heart, which is, however, beyond
the scope of my presentation.
Dr. Kolff is receiving the Jean Hamburger award for his
fundamental research in dialysis and for his development of the
first artificial kidney which could be used clinically with suc-
cess. His fundamental achievements were a prerequisite for the
later development of chronic dialysis and also for the develop-
ment of other forms of extracorporeal treatment, such as
hemofiltration, hemoperfusion and plasmapheresis.
I have heard from Dr. Kolff's friends and colleagues about his
keen sense of humor, and I have also experienced Kolff chairing
sessions, when he has been inquisitive, impatient and some-
times very critical. Dr. Robert Stephens working with him in
Salt Lake City has characterized him as catalytic, considering
his extraordinary ability to stimulate his scientific environment
by his enthusiasm. I also know that Dr. KoIff is a true humanist
with a serious concern for the future of mankind.
It is also my pleasure today to present Dr. Belding H.
Scribner, who shares the Jean Hamburger award with Dr. Kolif
at this Congress. Dr. Scribner was born in the United States in
1921. He has been attached to the University of Washington in
Seattle, Washington where he was professor of medicine and
chief of nephrology since 1962, and was appointed a personal
chair at the University of Washington in 1985.
Dr. Scribner had an early interest in electrolyte physiology
and biochemistry which constitutes an excellent background for
a clinical nephrologist. His most important achievements in
clinical nephrology started in 1960. At the meeting of the
American Society for Artificial Internal Organs that year he and
his co-workers presented two papers which had a decisive
influence on the later development of clinical nephrology.
In one paper the external arteriovenous shunt was described.
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The shunt made it possible to have access to the blood stream
repeatedly without having to sacrifice the peripheral blood
vessels. This opened for the first time the possibility to treat
patients with chronic renal failure with intermittent dialysis for
prolonged periods of time. The second paper described the
resutt of intermittent hemodialysis in two terminally uremic
patients with chronic renal failure. The patients not only
survived but improved to such a degree that they could leave
the hospital and go back to work.
At the first International Congress of Nephrology in Evian,
Seribner reported successful results in 4 patients on chronic
hemodialysis. At the second International Congress of Nephrol-
ogy in Prag 3 years later, Dr. Scribner could report that 18 out
of 19 patients with chronic renal failure treated by dialysis were
still alive and that 14 of these patients were almost completely
rehabilitated.
These results immediately stirred both enthusiasm and re-
sentment. Resentment came from part of the medical establish-
ment.
It cannot be overemphasized that the real technical break-
through in treatment of patients with chronic renal failure came
with the Scribner shunt. However, it would be a mistake to look
upon Seribner simply as a technical inventor.
Dr. Scribner not only showed that repeated hemodialyses
with short intervals were feasible, but also established a medi-
cal program which ensured long-term survival and rehabilita-
tion. He and his co-workers in Seattle were the first to encoun-
ter and describe most of the important medicat problems and
complications of chronic dialysis patients, such as fluid and
electrolyte disturbances, cardiovascular complications, ane-
mia, metastatie caleifieations, osteodystrophy and peripheral
neuropathy. The way Scribner and his group tackled all these
problems are excellent examples of clinical science at its best.
During more than two decades Seattle was the Mecca of
dialysis where more than a hundred nephrologists learned about
the wonders of the treatment and spread the message all over
the world.
Seribner and his group managed to simplify dialysis to the
extent that it could be performed and supervised by nurses, a
prerequisite for its expansion to a larger scale. They built the
first dialysate delivery systems based on proportioning of
concentrate and water and developed equipment suitable for
home hemodialysis. Dr. Seribner also initiated the development
of peritoneal dialysis for clinical use in patients with chronic
renal failure together with his co-workers Drs. S. Fred Bone
and Henrich Tenckhof.
Based on his observations of peripheral neuropathy in dialy-
sis patients Dr. Seribner was the first to propose that larger
molecules might be toxic in uremia. His so-called middle
molecule hypothesis stimulated the technical development of
more permeable membranes and more effective dialyzer de-
signs as well as the introduction of hemofiltration as an alter-
native method of treatment. We now have learned that Dr.
Seribner's basic concept of toxicity of larger molecules is right,
considering that f32-microglobulin, a protein with a molecular
weight of 11800 daltons, seems to be responsible for amyloi-
dosis with skeletal problems in long-term hemodialysis patients.
Dr. Seribner also encountered early the ethical, economical
and social problems created with the development of dialysis
treatment for end-stage renal failure, and worked very actively
to influence legislation so that all patients in need of treatment
should be provided necessary resources by their society.
Dr. Seribner is to my mind an exceptional personality, a
unique combination of creativity, ethical integrity, generosity
and humbleness. For those of you who do not know him I may
also tell that Scrib lives on a houseboat, wears a red cap,
paddles a canoe to his work and is a superb wine expert.
To conclude, both Willem Kolif and Belding Seribner have
contributed uniquely to the development of dialysis as an
established method of treatment for patients who have lost their
renal function, Kolif by creating the first artificial kidney for
successful clinical use, Seribner for initiating and establishing
chronic hemodialysis for treatment of chronic renal failure,
making it possible for the first time to replace a vital internal
organ permanently with an artificial device.
ISN Sponsorship of Meetings
The International Society of Nephrology (ISN) encourages
the organizers of scientific symposia, workshops, and confer-
ences held independently of the International Congress of
Nephrology to apply to hold these meetings under the auspices
of ISN.
In general, such an arrangement does not include an offer of
financial support on the part of ISN. In special eases, however,
the Society may be able to offer seed money.
Organizers who wish to apply to hold their meetings under
the auspices of the Society should include the following infor-
mation in their applications:
1. Topic and purpose of meeting.
2. Location and date of meeting.
3. Names of members of scientific organizing committee.
4. Names of co-sponsors and sources of financial support.
5. Names and topics of invited speakers.
6. Statement regarding whether or not free communications
will be sought.
Applications will not be accepted from organizers of regu-
larly, or routinely, scheduled regional, national, or international
meetings.
Applicants should be submitted to Dr. Claude Amiel, Secre-
tary General, ISN, Department de Physiologie, 16, rue Henri-
Huehard, 75018 Paris, France.
Publications and announcements of meetings held under
TSN's auspices should include the statement of acknowledge-
ment: ". . .was held under the auspices of the International
Society of Nephrology."
Membership
Any member of a national society of nephrology is eligible for
proposal to membership in the International Society of Nephro-
logy and receipt of the Society's official Journal, Kidney Inter-
national. A subscription to Kidney International (including all
Supplements) for calendar year 1988 is included in the annual
1988 dues of US $100.00. Potential members can secure appli-
cation forms for membership by writing directly to Dr. Robert
W. Sehrier, Treasurer, International Society of Nephrology,
Department of Medicine, University of Colorado Medical Cen-
ter, 4200 East Ninth Avenue, Denver, Colorado 80262, USA.
The completed application form must be signed by two spon-
sors who are current Fellow members of the ISN and then
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returned to Dr. Schrier along with a check or money order for
the first year's dues of $100.00. (Checks should be made
payable to the International Society of Nephrology. Checks
from outside the USA can be paid through any United States
bank.)
Guidelines for sponsorship of symposia, postgraduate
courses, or workshops by the International Society of
Nephrology
The International Society of Nephrology (ISN) encourages
the organizers of scientific symposia, postgraduate courses, or
workshops to apply to the Society for sponsorship. ISN spon-
sorship will provide: (1) use of the Society's name as a sponsor
or co-sponsor; (2) announcement of the meeting in Kidney
International, contingent upon the receipt of written informa-
tion in the Editorial office at least 6 months in advance of the
meeting; (3) the possibility of partial financial support. Appli-
cations must include the following information: (I) the topic,
purpose, location and date(s) of the meeting; (2) the names and
titles of the members of the scientific organizing committee; (3)
a list of all co-sponsoring institutions, if any, and sources of
financial support; (4) the total revenue and expense budget for
the proposed meeting, by major category; (5) the names and
institutions of origin of all invited speakers, and their topics; (6)
a statement as to whether manuscripts will be solicited from
invited speakers, or free communications sought from others;
(7) an expression of willingness to include the following ac-
knowledgment on all publications: ". . . was held under the
auspices of the International Society of Nephrology."
These guidelines do not apply to satellite symposia to be held
in close proximity to a triennial Congress. Furthermore, the
ISN will not sponsor or co-sponsor any regularly scheduled or
routine international, national, or regional meeting, nor will it
co-sponsor postgraduate courses with other international soci-
eties or groups.
Applications for sponsorship must be submitted directly to
Dr. Klaus Thurau, President, International Society of Nephrol-
ogy, Department of Physiology, University of Munich, 12
Pettenkoferstrasse, 8000 Munich 2, Federal Republic of Ger-
many.
Supplements to Kidney International
Limited funds are available for the partial financial support of
the direct cost of publication of the proceedings of meetings to
be published as Supplements to Kidney International. Individ-
ual awards cannot exceed US $5,000. Application must be made
to the Editor; it must include the date and place of the proposed
meeting, a list of other sponsors, a final program (including
speakers), an estimate of the number and length of manuscripts,
and an expression of willingness to participate in the editorial
process, including the submission of manuscripts to a modified
form of peer review.
ISN Archive
Dr. Carl Gottschalk has accepted the responsibility to estab-
lish an Archive of the International Society of Nephrology. The
Archive will consist of photographs, announcements, activities,
and names of Council Members and Officers of the Society.
Relevant information, documents, or photographs that are
pertinent to the development and evolution of the ISN will be
assembled in the Archive.
Members of the ISN or other readers of Kidney International
having such material are requested to forward it to Dr. Gottschalk
at the following address: Carl W. Gottschalk, M.D., Depart-
ment of Medicine 226-H, University of North Carolina, Chapel
Hill, North Carolina 27514 USA.
MEETINGS
The International Symposium on Renal Disease and Electro-
lyte Disorders, sponsored by the International Society of Neph-
rology, will be held in Nanjing, China on June 6—11, 1988. For
further information, contact Xue-Hai Du, M.D., Department of
Nephrology, China-Japan Friendship Hospital, Beijing, 100013,
People's Republic of China.
The Sixth Annual Meeting of the International Society of
Blood Purification will be held June 22—24, 1988 in Vicenza,
Italy. Topics of discussion will include: adsorption, apheresis,
CAPD, hemodialysis, immunomodulation, kinetic modeling,
liver support, membranes, toxin elimination, and clinical re-
sults. For further information, contact Dott. Claudio Ronco,
Associate of Clinical Nephrology, Department of Nephrology,
St. Bortolo Hospital ULSS8, Vicenza, Italy.
The American Society of Hypertension Third Annual Meet-
ing, including the Third World Congress on Biologically Active
Atrial Peptides, and the President's Symposium on Prorenin,
Renin and the Functional Characteristics of the Circulating and
Extrarenal Renin Systems, will be held June 22—26, 1988, at the
New York Hilton Hotel, New York, New York. For registra-
tion and housing forms, and for more information, contact
Carol Verneuil, CPC Communications, Box 4010, Greenwich,
CT 06830, (203)661-0600 or (212)993-0440, or The American
Society of Hypertension, Suite 2100, 515 Madison Avenue,
New York, New York 10022, (212)644-0650.
The 1988 European Society for Artificial Organs Meeting will
be held in Prague, Czechoslovakia on June 29—July 1, 1988.
Topics will include hemodialysis, peritoneal dialysis, hemofil-
tration, CAVH, hemoperfusion, plasmapheresis, immunomo-
dulation, biocompatibility, bioengineering, membrane technol-
ogy, blood access, orthopedics and prothesis. For further
information contact, Association of Czechoslovak Medical So-
cieties, J.E. Purkynje, P.O. Box 88, 120 26, Prague 2, Czecho-
slovakia.
The Silver Jubilee Year of the Postgraduate Institute of
Medical Education and Research, Chandigarh will be cele-
brated July 6 and 7, 1988. For a detailed program of events,
contact the Postgraduate Institute of Medical Education and
Research, Chandigarh 160012, India.
The 17th Congress of the South African Renal Society will
meet in Durban, South Africa on July 10—14, 1988. For further
information, contact D. S. Naicker, Department of Medicine,
University of Natal, P.O. Box 17039, Congella 4013, South
Africa.
The 7th Annual Meeting of the North American Symposium
for Dialysis and Transplantation will be held at the Stouffer's
Wailea Resort Hotel, Maui, Hawaii, on July 10—14, 1988. For
information, registration and abstract submission contact Dr.
Wadi N. Suki, Renal Section, 6565 Fannin, M.S. F-SOS, Hous-
ton, Texas 77030, USA. Telephone (713) 790-3275.
